| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |